{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:39:27Z","timestamp":1790419167646,"version":"4.1.0"},"reference-count":11,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.3201\/eid2511.190757","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T11:52:40Z","timestamp":1566474760000},"page":"2108-2111","source":"Crossref","is-referenced-by-count":107,"title":["Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019"],"prefix":"10.3201","volume":"25","author":[{"given":"Emi","family":"Takashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichiro","family":"Fujisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Shirakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideka","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Kishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Akimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Mitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takato","family":"Odagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2511.190757-201910111203-R1","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents.","volume":"379","author":"Hayden","year":"2018","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2511.190757-201910111203-R2","doi-asserted-by":"publisher","first-page":"9633","DOI":"10.1038\/s41598-018-27890-4","article-title":"Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil.","volume":"8","author":"Omoto","year":"2018","journal-title":"Sci Rep"},{"key":"key-10.3201\/eid2511.190757-201910111203-R3","unstructured":"Shionogi & Co. Ltd. Research and development at Shionogi. 2019 Mar 14 [cited 2019 May 27]. http:\/\/www.shionogi.co.jp\/en\/ir\/pdf\/e_p190314.pdf"},{"key":"key-10.3201\/eid2511.190757-201910111203-R4","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.3389\/fmicb.2018.03026","article-title":"Susceptibility of influenza viruses to the novel cap-dependent endonuclease inhibitor baloxavir marboxil.","volume":"9","author":"Takashita","year":"2018","journal-title":"Front Microbiol"},{"key":"key-10.3201\/eid2511.190757-201910111203-R5","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.12.1900170","article-title":"Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019.","volume":"24","author":"Takashita","year":"2019","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid2511.190757-201910111203-R6","first-page":"369","article-title":"Meetings of the WHO working group on surveillance of influenza antiviral susceptibility \u2013 Geneva, November 2011 and June 2012.","volume":"87","author":"World Health Organization","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"key-10.3201\/eid2511.190757-201910111203-R7","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.3.1800698","article-title":"Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018.","volume":"24","author":"Takashita","year":"2019","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid2511.190757-201910111203-R8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study.","volume":"364","author":"Kiso","year":"2004","journal-title":"Lancet"},{"key":"key-10.3201\/eid2511.190757-201910111203-R9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00006454-200102000-00002","article-title":"Oral oseltamivir treatment of influenza in children.","volume":"20","author":"Whitley","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2511.190757-201910111203-R10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1473-3099(09)70069-6","article-title":"Incubation periods of acute respiratory viral infections: a systematic review.","volume":"9","author":"Lessler","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2511.190757-201910111203-R11","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1086\/652241","article-title":"Viral shedding and clinical illness in naturally acquired influenza virus infections.","volume":"201","author":"Lau","year":"2010","journal-title":"J Infect Dis"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/25\/11\/19-0757_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:26:28Z","timestamp":1732987588000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/25\/11\/19-0757_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2511.190757","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}